INTERNATIONAL PATENT: TYRA BIOSCIENCES, INC. FILES APPLICATION FOR "TYRA-300 (5-[(1R)-1-(3,5-DICHLORO-4-PYRIDYL)ETHOXY]-3-[6-(2-METHYLSULFONYL-2,6-DIAZASPIRO[3.3]HEPTAN-6-YL)-3-PYRIDYL]-1H-INDAZOLE ) IN COMBINATION WITH A PD-1 OR PD-L1 ANTAGONIST FOR USE IN THE TREATMENT OF CANCER"

GENEVA, April 2 -- TYRA BIOSCIENCES, INC. (2656 State StreetCarlsbad, California 92008) filed a patent application (PCT/US2024/047589) for "TYRA-300 (5-[(1R)-1-(3,5-DICHLORO-4-PYRIDYL)ETHOXY]-3-[6-(2-METHYLSULFONYL-2,6-DIAZASPIRO[3.3]HEPTAN-6-YL)-3-PYRIDYL]-1H-INDAZOLE ) IN COMBINATION WITH A PD-1 OR PD-L1 ANTAGONIST FOR USE IN THE TREATMENT OF CANCER" on Sep 20, 2024. With publication no. WO/2025/064744, the details related to the patent application was published on Mar 27, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): TADA, Hiroomi (c/o Tyra Biosciences, Inc.2656 State StreetCarlsbad, Ca...